27532819|t|Self-Cloning CRISPR CRISPR/Cas9 - gene editing has emerged as a revolutionary technology to easily modify specific genomic loci by designing complementary sgRNA sequences and introducing these into cells along with Cas9. Self-cloning CRISPR/Cas9 (scCRISPR) uses a self-cleaving palindromic sgRNA plasmid (sgPal) that recombines with short PCR - amplified site-specific sgRNA sequences within the target cell by homologous recombination to circumvent the process of sgRNA plasmid construction. Through this mechanism, scCRISPR enables gene editing within 2 hr once sgRNA oligos are available, with high efficiency equivalent to conventional sgRNA targeting: >90% gene knockout in both mouse and human embryonic stem cells and cancer cell lines. Furthermore, using PCR-based addition of short homology arms, we achieve efficient site-specific knock-in of transgenes such as GFP without traditional plasmid cloning or genome-integrated selection cassette (2% to 4% knock-in rate). The methods in this paper describe the most rapid and efficient means of CRISPR gene editing. Â© 2016 by John Wiley & Sons, Inc.
27532819|a|Journal Article 2016-08-18 00:00:00
27532819	20	31	CRISPR/Cas9	T044	C3658355
27532819	34	46	gene editing	T063	C4277689
27532819	64	88	revolutionary technology	T090	C0039421
27532819	99	105	modify	T169	C0392747
27532819	106	114	specific	T080	C0205369
27532819	115	127	genomic loci	T028	C0678933
27532819	131	140	designing	T052	C1707689
27532819	141	154	complementary	T114	C0056208
27532819	155	170	sgRNA sequences	T114,T123	C0082774
27532819	198	203	cells	T025	C0007634
27532819	215	219	Cas9	T028	C0017337
27532819	221	245	Self-cloning CRISPR/Cas9	T028	C3661477
27532819	247	255	scCRISPR	T028	C3661477
27532819	264	289	self-cleaving palindromic	T114,T123	C2350254
27532819	290	303	sgRNA plasmid	T114,T123	C0082774
27532819	305	310	sgPal	T114,T123	C0082774
27532819	317	327	recombines	T052	C0441655
27532819	339	342	PCR	T063	C0032520
27532819	345	354	amplified	T045	C0017256
27532819	355	384	site-specific sgRNA sequences	T086	C0314659
27532819	396	402	target	T169	C1521840
27532819	403	407	cell	T025	C0007634
27532819	411	435	homologous recombination	T045	C0599773
27532819	454	461	process	T067	C1522240
27532819	465	478	sgRNA plasmid	T114,T123	C0082774
27532819	479	491	construction	T169	C0205245
27532819	506	515	mechanism	T169	C0441712
27532819	517	525	scCRISPR	T028	C3661477
27532819	534	546	gene editing	T063	C4277689
27532819	534	546	gene editing	T063	C4277689
27532819	564	569	sgRNA	T114,T123	C0082774
27532819	570	576	oligos	T114	C0028953
27532819	581	590	available	T169	C0470187
27532819	597	612	high efficiency	T081	C0013682
27532819	613	623	equivalent	T080	C0205163
27532819	627	639	conventional	T080	C0439858
27532819	640	645	sgRNA	T114,T123	C0082774
27532819	646	655	targeting	T169	C1521840
27532819	662	666	gene	T028	C0017337
27532819	667	675	knockout	T050	C1522225
27532819	684	689	mouse	T025	C4042879
27532819	694	720	human embryonic stem cells	T025	C1171346
27532819	725	742	cancer cell lines	T025	C0085983
27532819	763	772	PCR-based	T063	C0032520
27532819	791	804	homology arms	T028	C1334043
27532819	817	826	efficient	T080	C0442799
27532819	827	849	site-specific knock-in	T062	C1517676
27532819	853	863	transgenes	T028	C0282641
27532819	872	875	GFP	T116,T130	C0120285
27532819	884	895	traditional	T169	C0443324
27532819	896	903	plasmid	T114,T123	C0032136
27532819	904	911	cloning	T059,T063	C0598888
27532819	915	951	genome-integrated selection cassette	T028	C0017337
27532819	962	970	knock-in	T062	C1517676
27532819	971	975	rate	T081	C1521828
27532819	982	989	methods	T170	C0025663
27532819	1022	1027	rapid	T080	C0456962
27532819	1032	1041	efficient	T080	C0442799
27532819	1042	1047	means	T077	C1704970
27532819	1051	1057	CRISPR	T114	C3658200
27532819	1058	1070	gene editing	T063	C4277689